USFDA pulls up GRANULES for lapses in maintaining storage facilities
The US FDA issued a warning letter to GRANULES for violating Current Good Manufacturing Practice (CGMP) regulations at its Telangana plant. Inspectors found contamination in ducts, inadequate equipment maintenance, bird droppings, and torn CGMP records. The FDA demanded a corrective plan and timeline to address contamination, maintenance, and data integrity issues.
#StockInNews
250 likes·54 comments

















